Another study by Aihara K, et al. of adult gliomas limited to the thalamus revealed an ATRX mutation in 29% of the tumors while in our study it was 25% and was not just limited to thalamus but also included brainstem, intraventricular, spinal cord, and other unspecified locations [13]. Here, ATRX is linked to central nervous system cancer.